We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Humana Accuses Mallinckrodt of Price-Gouging for H.P. Acthar Gel
Humana Accuses Mallinckrodt of Price-Gouging for H.P. Acthar Gel
Humana is taking Mallinckrodt to court over an alleged price hiking scheme for its H.P. Acthar Gel (corticotropin) that the health insurance company says forced it to overpay by $700 million over more than eight years.